Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Hamzah

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
AIDS Patient Care and Stds|April 9, 2021
Reasons for Choice of Antiretroviral Regimens in HIV Patients Presenting Late for Initial Treatment in EuropeGundolf Schuettfort, Alfonso Cabello, Aoife G Cotter, et al.
International Journal of STD & AIDS|January 24, 2020
Surveying testing preferences in Black, Latin American, and other minorities for the co-design of digital vending machines for HIV self-testingMing J Lee, Denis Onyango, Husseina Hamza, et al.
HIV Medicine|March 26, 2024
HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in EnglandZoe Ottaway, Lucy Campbell, Julie Fox, et al.
International Journal of STD & AIDS|August 24, 2013
Kidney transplantation in HIV-positive adults: the UK experienceEsther N Gathogo, Lisa Hamzah, Rachel Hilton, et al.
International Journal of STD & AIDS|April 14, 2025
Post-acute sequelae of COVID-19 in people of Black ethnicities living with HIV in the United KingdomZoe Ottaway, Lucy Campbell, Julie Fox, et al.
BMC Nephrology|August 14, 2012
Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patientsLucy J Campbell, Tracy Dew, Rashim Salota, et al.
Antiviral Therapy|October 14, 2015
Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)Lisa Hamzah, Juan M Tiraboschi, Helen Iveson, et al.
HIV Medicine|August 29, 2024
Cardiovascular disease risk in people of African ancestry with HIV in the United KingdomStephanie Ko, Lourdes Dominguez-Dominguez, Zoe Ottaway, et al.
The Lancet. Infectious Diseases|December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trialGeorg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
AIDS Patient Care and Stds|April 9, 2021
Reasons for Choice of Antiretroviral Regimens in HIV Patients Presenting Late for Initial Treatment in EuropeGundolf Schuettfort, Alfonso Cabello, Aoife G Cotter, et al.
International Journal of STD & AIDS|January 24, 2020
Surveying testing preferences in Black, Latin American, and other minorities for the co-design of digital vending machines for HIV self-testingMing J Lee, Denis Onyango, Husseina Hamza, et al.
HIV Medicine|March 26, 2024
HIV outcomes during the COVID-19 pandemic in people of Black ethnicities living with HIV in EnglandZoe Ottaway, Lucy Campbell, Julie Fox, et al.
International Journal of STD & AIDS|August 24, 2013
Kidney transplantation in HIV-positive adults: the UK experienceEsther N Gathogo, Lisa Hamzah, Rachel Hilton, et al.
International Journal of STD & AIDS|April 14, 2025
Post-acute sequelae of COVID-19 in people of Black ethnicities living with HIV in the United KingdomZoe Ottaway, Lucy Campbell, Julie Fox, et al.
BMC Nephrology|August 14, 2012
Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patientsLucy J Campbell, Tracy Dew, Rashim Salota, et al.
Antiviral Therapy|October 14, 2015
Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)Lisa Hamzah, Juan M Tiraboschi, Helen Iveson, et al.
HIV Medicine|August 29, 2024
Cardiovascular disease risk in people of African ancestry with HIV in the United KingdomStephanie Ko, Lourdes Dominguez-Dominguez, Zoe Ottaway, et al.
The Lancet. Infectious Diseases|December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trialGeorg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
Pageof 6